Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib

Determination of the presence of epidermal growth factor receptor (EGFR) gene mutation is useful for predicting the efficacy of gefitinib. However, the survival rate following the initiation of treatment with gefitinib varies among individuals. A retrospective study was conducted to investigate the...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mol Clin Oncol
Huvudupphovsmän: INOMATA, MINEHIKO, HAYASHI, RYUJI, YAMAMOTO, AZUSA, TOKUI, KOTARO, TAKA, CHIHIRO, OKAZAWA, SEISUKE, KAMBARA, KENTA, SUZUKI, KENSUKE, ICHIKAWA, TOMOMI, YAMADA, TORU, MIWA, TOSHIRO, KASHII, TATSUHIKO, MATSUI, SHOKO, TOBE, KAZUYUKI, IMURA, JOHJI
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2015
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4486842/
https://ncbi.nlm.nih.gov/pubmed/26171184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.568
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk